Author:
Zhang Naiju,Su Tianjiao,Yan Jingwen,Zhang Mei,Zhao Shousong,Liu Chuanmiao,Chen Tianping
Abstract
Methazolamide is used to treat patients with glaucoma. However, as a sulfonamide derivative, methazolamide shares the same adverse reaction profile as other sulfa-based medications. Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare delayed-type hypersensitivity cutaneous reactions with high morbidity and mortality. Here, we report a severe SJS/TEN overlap syndrome in an 85-year-old Chinese male patient who received methazolamide 25 mg twice daily for his left eye glaucoma. The causal relationship between SJS/TEN and methazolamide was categorized as “highly likely” on the algorithm for assessing drug causality for epidermal necrolysis. In addition to the treatments with methylprednisolone and immunoglobulin, we used a special electromagnetic spectrum therapeutic apparatus to provide skin wound care. The patient had a thoroughly satisfying recovery. This is the first case report to use electromagnetic field therapy in a patient with SJS/TEN. We share our experience here and suggest that electromagnetic field therapy can provide advanced skin wound care and facilitate the recovery of SJS/TEN.
Reference16 articles.
1. Efficacy and safety of oral methazolamide in patients with type 2 diabetes: a 24-week, placebo-controlled, double-blind study;Simpson;Diabetes Care.,2014
2. Current perspectives on Stevens-Johnson Syndrome and toxic epidermal necrolysis;Lerch;Clin Rev Allergy Immunol.,2018
3. Toxic epidermal necrolysis: Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis;Schwartz;J Am Acad Dermatol.,2013
4. Death receptors in cutaneous biology and disease;Wehrli;J Invest Dermatol.,2000
5. Toxic epidermal necrolysis;Pereira;J Am Acad Dermatol.,2007
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Methazolamide;Reactions Weekly;2023-07-22